Research & Innovation

The future of European biotech may be taking shape in a former factory in Delft. A familiar building to me.

Six years after the COVID-19 pandemic fundamentally changed our perception of health security, one lesson remains undeniable: preparedness is not

For the past decades, Europe has been treating biotechnology primarily as a health policy issue. That was a mistake. Biotech

Health sovereignty today is not defined by physical control alone: stockpiles, warehouses or emergency reserves. Those still matter, but the

A sector already delivering for Europe Europe remains one of the world’s leading vaccine development and manufac turing ecosystems and

Europe’s ambition to secure health sovereignty through global leadership in advanced therapies is now a central policy priority—both timely and

The European Biotech Act represents one of the most significant attempts in recent years to strengthen Europe’s position in biotechnology